Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Dunn

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Agents and Actions|February 1, 1975
The mast cells of the newborn rat diaphragm and their response to histamine liberatorsC J Dunn, D A Willoughby, J P Giroud
Annals of Internal Medicine|November 1, 1988
Slow release of interleukin-2 from polymer implantsC J Dunn, N D Staite, M M Hardee
Agents and Actions|June 1, 1989
The effects of sensitization protocols on arthritic responses in antigen-induced arthritisN D Staite, L G Cutshaw, C J Dunn
Idrugs : the Investigational Drugs Journal|May 10, 2008
Bisphosphonates: a review of their novel anti-inflammatory properties and potential for the treatment of rheumatoid arthritisC J Dunn, J G Slatter, R A Nugent
Inflammation|July 1, 1979
Leukocyte migration inhibition activity of nonimmune acute inflammatory pleural exudateA M Sultan, C J Dunn, D A Willoughby
Inflammation|July 1, 1979
The role of kallikrein in leukocyte migration inhibitionA M Sultan, C J Dunn, D A Willoughby
The Journal of Pathology|June 1, 1979
Potassium permanganate induced calcergy: a model to study the effects of drugs on hydroxyapatite crystal depositionD V Doyle, C J Dunn, D A Willoughby
Agents and Actions|June 1, 1989
Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in miceC J Dunn, M M Hardee, N D Staite
Agents and Actions|June 1, 1989
Development of a delayed-type hypersensitivity granuloma model in the mouse for the study of chronic immune-mediated inflammatory diseaseC J Dunn, A J Gibbons, S K Miller
Drugs|July 1, 1997
Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disordersC J Dunn, A P Lea, A J Wagstaff
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Agents and Actions|February 1, 1975
The mast cells of the newborn rat diaphragm and their response to histamine liberatorsC J Dunn, D A Willoughby, J P Giroud
Annals of Internal Medicine|November 1, 1988
Slow release of interleukin-2 from polymer implantsC J Dunn, N D Staite, M M Hardee
Agents and Actions|June 1, 1989
The effects of sensitization protocols on arthritic responses in antigen-induced arthritisN D Staite, L G Cutshaw, C J Dunn
Idrugs : the Investigational Drugs Journal|May 10, 2008
Bisphosphonates: a review of their novel anti-inflammatory properties and potential for the treatment of rheumatoid arthritisC J Dunn, J G Slatter, R A Nugent
Inflammation|July 1, 1979
Leukocyte migration inhibition activity of nonimmune acute inflammatory pleural exudateA M Sultan, C J Dunn, D A Willoughby
Inflammation|July 1, 1979
The role of kallikrein in leukocyte migration inhibitionA M Sultan, C J Dunn, D A Willoughby
The Journal of Pathology|June 1, 1979
Potassium permanganate induced calcergy: a model to study the effects of drugs on hydroxyapatite crystal depositionD V Doyle, C J Dunn, D A Willoughby
Agents and Actions|June 1, 1989
Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in miceC J Dunn, M M Hardee, N D Staite
Agents and Actions|June 1, 1989
Development of a delayed-type hypersensitivity granuloma model in the mouse for the study of chronic immune-mediated inflammatory diseaseC J Dunn, A J Gibbons, S K Miller
Drugs|July 1, 1997
Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disordersC J Dunn, A P Lea, A J Wagstaff
Pageof 11